2025 CiteScore: 0.7
pISSN: 2383-4196
eISSN: 2383-420X
Editor-in-Chief:
Hojjat Zeraati, Ph.D.
Author Guidelines
Authors are requested to read these guidelines carefully before preparing and submitting a manuscript. Manuscripts not conforming to these guidelines may be returned without review.
|
Article Type |
Word Limit |
Abstract |
References |
|
Original Research |
≤6,000 |
Structured ≤300 words |
≤50 |
|
Methodological Paper |
≤7,000 |
Structured ≤300 words |
≤60 |
|
Systematic Review / Meta-Analysis |
≤8,000 |
Structured ≤350 words |
No limit |
|
Short Communication |
≤2,500 |
Unstructured ≤150 words |
≤20 |
|
Tutorial / Technical Note |
≤5,000 |
Unstructured ≤200 words |
≤40 |
|
Registered Report (Stage 1) |
≤4,000 |
Structured ≤250 words |
≤40 |
|
Software / Data Report |
≤3,000 |
Unstructured ≤150 words |
≤25 |
|
Editorial / Perspective |
≤2,000 |
None |
≤15 |
By submitting a manuscript, all authors confirm that:
3.1 Title Page (separate file)
The title page must include:
3.2 Abstract
Structured abstracts (≤300 words) are required for Original Research, Methodological Papers, and Systematic Reviews, using the following headings:
The abstract must be self-contained and must not cite references. Abbreviations should be avoided unless standard. Abstracts are indexed by PubMed, Scopus, and Web of Science and serve as the primary means by which readers discover articles; they should accurately and completely summarize the study.
3.3 Keywords
Provide 5–8 keywords immediately following the abstract. Keywords should be selected from MeSH (Medical Subject Headings) where applicable. Avoid repeating words already in the title. Keywords directly influence indexing and discoverability in PubMed, Scopus, and Web of Science.
3.4 Main Text Structure
Original research articles should be organized as follows:
Introduction: Background, knowledge gap, and objectives. End with a clear statement of the study aim.
Methods: Study design and setting; participants/data sources; variables and measurements; statistical analysis plan including software and version; ethical approval statement. Sufficient detail to permit replication.
Results: Report findings objectively. Present all primary and key secondary outcomes. Include exact p-values (not p<0.05), effect sizes with 95% confidence intervals.
Discussion: Interpret findings in context of existing literature; address limitations explicitly; discuss generalizability; consider clinical and public health implications.
Conclusions: Brief, evidence-based conclusions directly supported by the results. Avoid overgeneralizations.
Conflict of Interest: Required for all manuscripts.
Funding: Required for all manuscripts.
Data Availability Statement: Required for all manuscripts.
Author Contributions: Using CRediT (Contributor Roles Taxonomy).
References: Vancouver style, consecutively numbered.
Tables and Figures: At end of manuscript or as separate files.
3.5 Reporting Guidelines
Authors must follow and cite the appropriate reporting guideline for their study type. JBE requires completion of the relevant reporting checklist as a condition of submission:
Randomized controlled trials: CONSORT (with appropriate extension: cluster, pilot, etc.)
Observational studies (cohort, case-control, cross-sectional): STROBE
Systematic reviews and meta-analyses: PRISMA (with relevant extension: NMA, IPD, etc.)
Diagnostic/prognostic accuracy studies: TRIPOD / STARD
Clinical prediction models (development/validation): TRIPOD+AI (for AI-based models)
Qualitative research: COREQ or SRQR
Economic evaluations: CHEERS
Animal studies: ARRIVE 2.0
AI/ML studies: CONSORT-AI, SPIRIT-AI, TRIPOD-AI as applicable
Registered Reports: JBE Registered Report template
3.6 Statistical Reporting Standards
JBE follows the recommendations of the American Statistical Association (ASA) on p-values and statistical significance. Authors are required to:
Figures
Tables
JBE uses Vancouver reference style. References are numbered consecutively in the order they first appear in the text, using superscript numerals. Reference list entries follow ICMJE format. Include DOIs for all references where available.
Example (journal article):
Zhang Y, Wang X, Li J, Chen H. Bayesian hierarchical modeling of COVID-19 infection dynamics across multiple regions. J Biostat Epidemiol. 2022;8(2):120–135. doi:10.18502/jbe.v8i2.XXXX
JBE is committed to reproducible research. All authors are required to include a Data Availability Statement. Authors are strongly encouraged to:
Authors may use AI-assisted tools (including large language models, chatbots, and AI writing assistants) for grammar checking, language editing, or organizational assistance. Any such use must be explicitly disclosed in the Methods section or an AI Use Disclosure statement. Authors must specify the tool, version, and purpose of use. AI tools cannot be listed as authors and cannot be used to generate, fabricate, or misrepresent scientific content, data, or interpretations. The full responsibility for the accuracy, originality, and integrity of all content remains with the human authors. See the AI and Generative AI Policy for full details.

![]() |
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |